Wutah pendapatan taun lumaku: Biofrontera Inc. (BFRI)

Logo grafis Biofrontera (BFRI)

Biofrontera Inc. focuses on the implementation of photodynamic therapy systems and acne treatments in the US. Looking at the annual sales growth over a 12-month period on GURU.Markets, it is evident that profit is based on the sales of BF-RhodoLED and Ameluz lamps. Growth is supported by packaging automation and software robots within the clinic. Meanwhile, the value of 29.30 serves as the baseline indicator for current dynamics.

BFRI: Wutah dodolan YoY sajrone rolas wulan kepungkur Biofrontera Inc. 11.02.2024 - 15.11.2026

Ringkesan rincian data analitis biofrontera-us.com (BFRI)

- nilai saham lan prakiraan konsensus rega:
- indikator kapitalisasi bursa perusahaan:
Pambiji fundamental perusahaan:biofrontera-us.com BFRI
Produk asil prodhuksi Biofrontera Inc.

Professional selection of resilient assets is based on an analysis of revenue growth rates, where a positive trend confirms the business's market expansion. The trailing 12-month (TTM) sales dynamics reflect the year-over-year percentage change in revenue, which for Biofrontera Inc. (BFRI) highlights the stability of consumables turnover due to the integration of pharmaceuticals into strict medical protocols.